Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Hosseinzadeh Z, Sopjani M, Pakladok T, Bhavsar SK, Lang F.
???displayArticle.abstract???
Janus kinase-2 (JAK2) participates in the signaling of several hormones, growth factors and cytokines. Further stimulators of JAK2 include osmotic cell shrinkage, and the kinase activates the cell volume regulatory Na(+)/H(+) exchanger. The kinase may thus participate in cell volume regulation. Cell shrinkage is known to inhibit K(+) channels. Volume-regulatory K(+) channels include the voltage-gated K(+) channel KCNQ4. The present study explored the effect of JAK2 on KCNQ4 channel activity. KCNQ4 was expressed in Xenopus oocytes with or without wild-type JAK2, constitutively active (V617F)JAK2 or inactive (K882E)JAK2; and cell membrane conductance was determined by dual-electrode voltage clamp. Expression of KCNQ4 was followed by the appearance of voltage-gated K(+) conductance. Coexpression of JAK2 or of (V617F)JAK2, but not of (K882E)JAK2, resulted in a significant decrease in conductance. Treatment of KCNQ4 and JAK2 coexpressing oocytes with the JAK2 inhibitor AG490 (40 μM) was followed by an increase in conductance. Treatment of KCNQ4 expressing oocytes with brefeldin A (5 μM) was followed by a decrease in conductance, which was similar in oocytes expressing KCNQ4 together with JAK2 as in oocytes expressing KCNQ4 alone. Thus, JAK2 apparently does not accelerate channel protein retrieval from the cell membrane. In conclusion, JAK2 downregulates KCNQ4 activity and thus counteracts K(+) exit, an effect which may contribute to cell volume regulation.
Banes-Berceli,
Angiotensin II utilizes Janus kinase 2 in hypertension, but not in the physiological control of blood pressure, during low-salt intake.
2011, Pubmed
Banes-Berceli,
Angiotensin II utilizes Janus kinase 2 in hypertension, but not in the physiological control of blood pressure, during low-salt intake.
2011,
Pubmed Baskin,
The recent medicinal chemistry development of Jak2 tyrosine kinase small molecule inhibitors.
2010,
Pubmed Bhavsar,
Stimulation of the amino acid transporter SLC6A19 by JAK2.
2011,
Pubmed
,
Xenbase Böhmer,
The serum and glucocorticoid inducible kinases SGK1-3 stimulate the neutral amino acid transporter SLC6A19.
2010,
Pubmed
,
Xenbase Brooks,
The growth hormone receptor: mechanism of activation and clinical implications.
2010,
Pubmed Dërmaku-Sopjani,
Downregulation of NaPi-IIa and NaPi-IIb Na-coupled phosphate transporters by coexpression of Klotho.
2011,
Pubmed
,
Xenbase Eckey,
Modulation of human ether a gogo related channels by CASQ2 contributes to etiology of catecholaminergic polymorphic ventricular tachycardia (CPVT).
2010,
Pubmed
,
Xenbase Feng,
Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop.
1997,
Pubmed Garnovskaya,
Hypertonicity activates Na+/H+ exchange through Janus kinase 2 and calmodulin.
2003,
Pubmed Gatsios,
Activation of the Janus kinase/signal transducer and activator of transcription pathway by osmotic shock.
1998,
Pubmed Hammami,
Cell volume and membrane stretch independently control K+ channel activity.
2009,
Pubmed
,
Xenbase Heidenreich,
KCNQ4 K(+) channels tune mechanoreceptors for normal touch sensation in mouse and man.
2011,
Pubmed Henrion,
Tracking a complete voltage-sensor cycle with metal-ion bridges.
2012,
Pubmed
,
Xenbase Ho,
JAK2 Translocations in hematological malignancies: Review of the literature.
2010,
Pubmed Hosseinzadeh,
Up-regulation of the betaine/GABA transporter BGT1 by JAK2.
2012,
Pubmed
,
Xenbase Hosseinzadeh,
Downregulation of ClC-2 by JAK2.
2012,
Pubmed
,
Xenbase Hosseinzadeh,
Regulation of the glutamate transporters by JAK2.
2011,
Pubmed
,
Xenbase Hosseinzadeh,
Stimulation of the glucose carrier SGLT1 by JAK2.
2011,
Pubmed
,
Xenbase Hougaard,
Modulation of KCNQ4 channel activity by changes in cell volume.
2004,
Pubmed Hunziker,
Brefeldin A and the endocytic pathway. Possible implications for membrane traffic and sorting.
1992,
Pubmed Jepps,
Molecular and functional characterization of Kv7 K+ channel in murine gastrointestinal smooth muscles.
2009,
Pubmed Jepps,
Downregulation of Kv7.4 channel activity in primary and secondary hypertension.
2011,
Pubmed Joshi,
KCNQ modulators reveal a key role for KCNQ potassium channels in regulating the tone of rat pulmonary artery smooth muscle.
2009,
Pubmed Lang,
Ion channels and cell volume in regulation of cell proliferation and apoptotic cell death.
2006,
Pubmed Lang,
Functional significance of cell volume regulatory mechanisms.
1998,
Pubmed Lopez,
Molecular basis of cytokine receptor activation.
2010,
Pubmed Macri,
Hypertonicity decreases basolateral K+ and Cl- conductances in rabbit proximal convoluted tubule.
1997,
Pubmed Mahfouz,
JAK2 V617F gene mutation in the laboratory work-up of myeloproliferative disorders: experience of a major referral center in Lebanon.
2011,
Pubmed Mistry,
Novel expression and regulation of voltage-dependent potassium channels in placentas from women with preeclampsia.
2011,
Pubmed Morris,
Recent advances in understanding leptin signaling and leptin resistance.
2009,
Pubmed Nie,
KCNQ4 mutations associated with nonsyndromic progressive sensorineural hearing loss.
2008,
Pubmed Oh,
JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms.
2010,
Pubmed Pardanani,
JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations.
2011,
Pubmed Rexhepaj,
Stimulation of electrogenic glucose transport by glycogen synthase kinase 3.
2010,
Pubmed
,
Xenbase Santos,
JAK2 inhibitors: what's the true therapeutic potential?
2011,
Pubmed Seebohm,
Regulation of KCNQ4 potassium channel prepulse dependence and current amplitude by SGK1 in Xenopus oocytes.
2005,
Pubmed
,
Xenbase Shojaiefard,
Downregulation of the creatine transporter SLC6A8 by JAK2.
2012,
Pubmed
,
Xenbase Sotty,
Antipsychotic-like effect of retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic acid ester], a KCNQ potassium channel opener, via modulation of mesolimbic dopaminergic neurotransmission.
2009,
Pubmed Spivak,
Narrative review: Thrombocytosis, polycythemia vera, and JAK2 mutations: The phenotypic mimicry of chronic myeloproliferation.
2010,
Pubmed Staub,
Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination.
1997,
Pubmed
,
Xenbase Strutz-Seebohm,
Structural basis of slow activation gating in the cardiac I Ks channel complex.
2011,
Pubmed
,
Xenbase Strutz-Seebohm,
Functional coassembly of KCNQ4 with KCNE-beta- subunits in Xenopus oocytes.
2006,
Pubmed
,
Xenbase Tefferi,
Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics.
2009,
Pubmed Tefferi,
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1.
2010,
Pubmed Walter,
A genome-wide association study of aging.
2011,
Pubmed Wang,
K(V)7/KCNQ channels are functionally expressed in oligodendrocyte progenitor cells.
2011,
Pubmed Wei,
Effects of chloride and potassium channel blockers on apoptotic cell shrinkage and apoptosis in cortical neurons.
2004,
Pubmed
